Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Alpesh Amin

Hospital Medicine · UCI

View

Dr. Akua Ampadu

Hospital Medicine · NYP Weill Cornell

View

Dr. Reza Manesh

Hospital Medicine · Greater Los Angeles VA

View

Dr. Michael Calavano

Hospital Medicine · NYP Weill Cornell

View

Dr. Nasim Afsar

Hospital Medicine

View

Dr. Sara Murray

Hospital Medicine · Johns Hopkins Medicine

View

Dr. Robert Korom

Hospital Medicine · Penda Health

View

Dr. Sunil Kripalani

Hospital Medicine · VUMC

View

Dr. Ronald Greeno

Hospital Medicine · Society of Hospital Medicine

View

Dr. Moises Auron

Hospital Medicine · Cleveland Clinic

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RM

    Dr. Reema Mody

    Internal Medicine · Hospital Medicine
    Hackensack University Medical Center
    reema

    Research

    Characteristics and Dosing Patterns of Tirzepatide Users with Type 2 Diabetes in the United States.

    2025

    Via Diabetes therapy : research, treatment and education of diabetes and related disorders

    Research

    Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States.

    2025

    Via Diabetes, obesity & metabolism

    Research

    Tirzepatide 10 and 15 mg vs semaglutide 2.0 mg: A long-term cost-effectiveness analysis in patients with type 2 diabetes in the United States.

    2024

    Via Journal of managed care & specialty pharmacy

    Research

    Long-term cost-effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States.

    2023

    Via Diabetes, obesity & metabolism

    Research

    Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States.

    2023

    Via Diabetes therapy : research, treatment and education of diabetes and related disorders

    Research

    Greater Adherence and Persistence with Injectable Dulaglutide Compared with Injectable Semaglutide at 1-Year Follow-up: Data from US Clinical Practice.

    2022

    Via Clinical therapeutics

    Research

    Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison.

    2022

    Via Diabetes, obesity & metabolism

    Research

    Association of Dulaglutide Initiation Timing With Treatment Patterns and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus in the United States.

    2022

    Via Clinical therapeutics

    Research

    Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States.

    2022

    Via Current medical research and opinion

    Research

    Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study.

    2022

    Via Diabetes therapy : research, treatment and education of diabetes and related disorders

    Research

    Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD-11.

    2021

    Via Diabetes, obesity & metabolism

    Research

    Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND.

    2021

    Via Cardiovascular diabetology

    Research

    The Health Care Resource Utilization and Costs Among Patients With Type 2 Diabetes and Either Cardiovascular Disease or Cardiovascular Risk Factors An Analysis of a US Health Insurance Database.

    2021

    Via Clinical therapeutics

    Research

    Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents.

    2020

    Via Diabetes therapy : research, treatment and education of diabetes and related disorders

    Research

    Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review.

    2020

    Via Diabetes therapy : research, treatment and education of diabetes and related disorders